NogoA expression was markedly upregulated in surviving oligodendrocytes at the edge of chronic active demyelinating lesions of MS, whereas NgR was found to be significantly increased in reactive astrocytes and microglia/macrophages in these lesions [52]. The gene discussed is RTN4; the disease is myeloid sarcoma.